$DJCO
DAILY JOURNAL CORP

2024 Q1 Form 10-Q Financial Statement

#000143774924004225 Filed on February 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4
Revenue $16.57M $15.99M
YoY Change 2.58% 30.01%
Cost Of Revenue $1.743M $1.872M
YoY Change 12.74% 45.34%
Gross Profit $14.83M $14.12M
YoY Change 1.51% 28.22%
Gross Profit Margin 89.48% 88.29%
Selling, General & Admin $14.24M $13.61M
YoY Change 10.55% 13.76%
% of Gross Profit 96.03% 96.37%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $67.00K $66.00K
YoY Change -4.29% -12.0%
% of Gross Profit 0.45% 0.47%
Operating Expenses $15.94M $15.37M
YoY Change 9.7% 18.08%
Operating Profit $633.0K $623.0K
YoY Change -61.05% -187.01%
Interest Expense $19.99M $15.12M
YoY Change 71.67% -38.66%
% of Operating Profit 3157.5% 2426.48%
Other Income/Expense, Net
YoY Change
Pretax Income $20.62M $15.74M
YoY Change 55.41% -34.22%
Income Tax $5.205M $3.125M
% Of Pretax Income 25.24% 19.85%
Net Earnings $15.42M $12.62M
YoY Change 63.42% -29.24%
Net Earnings / Revenue 93.02% 78.88%
Basic Earnings Per Share $11.19 $9.16
Diluted Earnings Per Share $11.19 $9.16
COMMON SHARES
Basic Shares Outstanding 1.377M 1.377M
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $307.6M $332.3M
YoY Change -7.5% 3.27%
Cash & Equivalents $10.56M $14.43M
Short-Term Investments $297.0M $317.8M
Other Short-Term Assets $3.180M $2.911M
YoY Change 10.26% -5.09%
Inventory $64.00K $58.00K
Prepaid Expenses
Receivables $15.62M $12.74M
Other Receivables $0.00 $21.00K
Total Short-Term Assets $326.4M $348.0M
YoY Change -6.6% 3.36%
LONG-TERM ASSETS
Property, Plant & Equipment $9.250M $9.299M
YoY Change -2.45% -2.26%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $9.319M $9.381M
YoY Change -2.24% -2.19%
TOTAL ASSETS
Total Short-Term Assets $326.4M $348.0M
Total Long-Term Assets $9.319M $9.381M
Total Assets $335.7M $357.4M
YoY Change -6.48% 3.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.070M $6.019M
YoY Change 37.36% 14.23%
Accrued Expenses $6.054M $5.032M
YoY Change 27.94% 19.81%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $161.0K $160.0K
YoY Change 3.87% 3.9%
Total Short-Term Liabilities $36.40M $34.71M
YoY Change 16.46% 10.89%
LONG-TERM LIABILITIES
Long-Term Debt $30.46M $71.08M
YoY Change -62.94% -13.6%
Other Long-Term Liabilities $4.746M $4.942M
YoY Change 7.77% 10.02%
Total Long-Term Liabilities $70.85M $109.6M
YoY Change -41.68% -7.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $36.40M $34.71M
Total Long-Term Liabilities $70.85M $109.6M
Total Liabilities $107.2M $144.3M
YoY Change -29.79% -3.45%
SHAREHOLDERS EQUITY
Retained Earnings $226.7M $211.3M
YoY Change 10.87% 8.33%
Common Stock $14.00K $14.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $228.5M $213.1M
YoY Change
Total Liabilities & Shareholders Equity $335.7M $357.4M
YoY Change -6.48% 3.2%

Cashflow Statement

Concept 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income $15.42M $12.62M
YoY Change 63.42% -29.24%
Depreciation, Depletion And Amortization $67.00K $66.00K
YoY Change -4.29% -12.0%
Cash From Operating Activities -$3.651M -$1.162M
YoY Change 446.56% -148.46%
INVESTING ACTIVITIES
Capital Expenditures $18.00K $5.000K
YoY Change -52.63% -86.11%
Acquisitions
YoY Change
Other Investing Activities $40.58M $0.00
YoY Change -100.0%
Cash From Investing Activities $40.56M -$5.000K
YoY Change -106839.47% -99.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -40.62M -$5.039M
YoY Change 62390.77% -184.15%
NET CHANGE
Cash From Operating Activities -3.651M -$1.162M
Cash From Investing Activities 40.56M -$5.000K
Cash From Financing Activities -40.62M -$5.039M
Net Change In Cash -3.709M -$6.206M
YoY Change 381.06% -628.17%
FREE CASH FLOW
Cash From Operating Activities -$3.651M -$1.162M
Capital Expenditures $18.00K $5.000K
Free Cash Flow -$3.669M -$1.167M
YoY Change 419.69% -149.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
303128000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
250000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18687000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
72000 usd
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
21000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20844000 usd
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
2100000 usd
CY2023Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
CY2023Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2023Q4 dei Amendment Flag
AmendmentFlag
false
CY2023Q4 dei Entity Central Index Key
EntityCentralIndexKey
0000783412
CY2023Q3 djco Deferred Compensation Plan Trust Assets
DeferredCompensationPlanTrustAssets
194000 usd
CY2023Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0 usd
CY2023Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4003000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
179017000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
17827000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
196844000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
200469000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
12615000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
213084000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
12615000 usd
CY2023Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
66000 usd
CY2022Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
75000 usd
CY2022Q4 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
24025000 usd
CY2023Q4 djco Marketable Securities Net Gain Loss
MarketableSecuritiesNetGainLoss
-0 usd
CY2022Q4 djco Marketable Securities Net Gain Loss
MarketableSecuritiesNetGainLoss
422000 usd
CY2023Q4 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
2950000 usd
CY2022Q4 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
6097000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5945000 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5553000 usd
CY2023Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-14000 usd
CY2022Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
25000 usd
CY2023Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
18000 usd
CY2022Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-68000 usd
CY2023Q4 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
21000 usd
CY2022Q4 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-2000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-624000 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
207000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3125000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15740000 usd
CY2022Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3408000 usd
CY2023Q4 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1069000 usd
CY2022Q4 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1162000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2398000 usd
CY2022Q4 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
2826000 usd
CY2022Q4 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
10001000 usd
CY2023Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5000 usd
CY2022Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7211000 usd
CY2022Q4 us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
6011000 usd
CY2023Q4 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
5000000 usd
CY2023Q4 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
39000 usd
CY2022Q4 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
23000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5039000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5988000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6206000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1175000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
23138000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15468000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16932000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16643000 usd
CY2023Q4 us-gaap Interest Paid Net
InterestPaidNet
1232000 usd
CY2022Q4 us-gaap Interest Paid Net
InterestPaidNet
917000 usd
CY2023Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1265000 usd
CY2022Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q4 us-gaap Basis Of Accounting
BasisOfAccounting
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Note 2 - Basis of Presentation</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 18pt;">In the opinion of the Company, the accompanying interim unaudited consolidated financial statements contain all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of its financial position as of December 31, 2023, its results of operations for the three-month periods ended December 31, 2023 and 2022, its consolidated statements of shareholders’ equity for the three-month periods ended December 31, 2023 and 2022 and cash flows for the three-month periods ended December 31, 2023 and 2022. The results of operations for the three months ended December 31, 2023 are not necessarily indicative of the results to be expected for the full year.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 18pt;">The consolidated financial statements included herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented not misleading. These financial statements should be read in conjunction with the financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended September 30, 2023.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 18pt;">Certain reclassifications of previously reported amounts have been made to conform to the current year’s presentation.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023Q4 djco Office Lease Obligations Beyond One Year
OfficeLeaseObligationsBeyondOneYear
31000 usd
CY2022Q2 djco Receipt Of Donated Treasury Stock Shares
ReceiptOfDonatedTreasuryStockShares
3720
CY2022Q2 djco Value Of Donated Treasury Shares
ValueOfDonatedTreasuryShares
1000000 usd
CY2022Q2 djco Receipt Of Donated Treasury Stock Shares
ReceiptOfDonatedTreasuryStockShares
3720
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1377026
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1377026
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1377026
CY2023Q4 djco Marketable Securities Accumulated Unrealized Gain Loss
MarketableSecuritiesAccumulatedUnrealizedGainLoss
152406000 usd
CY2023Q3 djco Marketable Securities Accumulated Unrealized Gain Loss
MarketableSecuritiesAccumulatedUnrealizedGainLoss
137716000 usd
CY2023Q4 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
14690000 usd
CY2023 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-24025000 usd
CY2022Q4 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
2826000 usd
CY2022Q4 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
422000 usd
CY2022Q4 djco Borrowed Funds From Margin Loan Account
BorrowedFundsFromMarginLoanAccount
6011000 usd
CY2022Q4 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
10001000 usd
CY2023Q1 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
11000 usd
CY2023Q4 djco Income Tax Reconciliation Realized Gains On Marketable Securities
IncomeTaxReconciliationRealizedGainsOnMarketableSecurities
3765000 usd
CY2023Q4 djco Income Tax Reconciliation Unrealized Gains Losses On Marketable Securities
IncomeTaxReconciliationUnrealizedGainsLossesOnMarketableSecurities
30000 usd
CY2023Q4 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
270000 usd
CY2023Q4 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
120000 usd
CY2023Q4 us-gaap Income Tax Reconciliation Deductions Dividends
IncomeTaxReconciliationDeductionsDividends
820000 usd
CY2023Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.199 pure
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6100000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23927000 usd
CY2022Q4 djco Income Tax Reconciliation Unrealized Gains Losses On Marketable Securities
IncomeTaxReconciliationUnrealizedGainsLossesOnMarketableSecurities
110000 usd
CY2022Q4 djco Income Tax Reconciliation Realized Gains On Marketable Securities
IncomeTaxReconciliationRealizedGainsOnMarketableSecurities
6360000 usd
CY2022Q4 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
140000 usd
CY2022Q4 us-gaap Income Tax Reconciliation Deductions Dividends
IncomeTaxReconciliationDeductionsDividends
80000 usd
CY2022Q4 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
150000 usd
CY2022Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2549 pure
CY2023Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
387000 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
15993000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12301000 usd
CY2023Q4 us-gaap Labor And Related Expense
LaborAndRelatedExpense
11347000 usd
CY2022Q4 us-gaap Labor And Related Expense
LaborAndRelatedExpense
9631000 usd
CY2023Q4 djco Decrease Increase To The Longterm Supplemental Compensation Accrual
DecreaseIncreaseToTheLongtermSupplementalCompensationAccrual
-420000 usd
CY2022Q4 djco Decrease Increase To The Longterm Supplemental Compensation Accrual
DecreaseIncreaseToTheLongtermSupplementalCompensationAccrual
-520000 usd
CY2023Q4 us-gaap Other General Expense
OtherGeneralExpense
4443000 usd
CY2022Q4 us-gaap Other General Expense
OtherGeneralExpense
3906000 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
15370000 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
13017000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
623000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-716000 usd
CY2023Q4 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1569000 usd
CY2022Q4 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1069000 usd
CY2023Q4 djco Marketable Securities Net Gain Loss
MarketableSecuritiesNetGainLoss
0 usd
CY2022Q4 djco Marketable Securities Net Gain Loss
MarketableSecuritiesNetGainLoss
422000 usd
CY2023Q4 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
14690000 usd
CY2022Q4 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
24025000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15740000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23927000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3125000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6100000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
12615000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
17827000 usd
CY2023Q4 us-gaap Assets
Assets
357363000 usd
CY2022Q4 us-gaap Assets
Assets
346271000 usd
CY2023Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5000 usd
CY2022Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36000 usd

Files In Submission

Name View Source Status
0001437749-24-004225-index-headers.html Edgar Link pending
0001437749-24-004225-index.html Edgar Link pending
0001437749-24-004225.txt Edgar Link pending
0001437749-24-004225-xbrl.zip Edgar Link pending
djco-20231231.xsd Edgar Link pending
djco-20231231_cal.xml Edgar Link unprocessable
djco-20231231_def.xml Edgar Link unprocessable
djco-20231231_lab.xml Edgar Link unprocessable
djco20231231_10q.htm Edgar Link pending
ex_625033.htm Edgar Link pending
ex_625034.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
djco20231231_10q_htm.xml Edgar Link completed
djco-20231231_pre.xml Edgar Link unprocessable